Insider Transactions Reported by 15 Insiders of TFF Pharmaceuticals, Inc.

Location
Austin, TX

There are no Buy or Sell transactions made by insiders since 14 Mar 2025

TFF Pharmaceuticals, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Carlson Capital, L.P. 10%+ Owner $4,198,493 15 Aug 2023
Malcolm P. Fairbairn Director $519,876 19 May 2021
Harlan F. Weisman President and CEO, Director $347,373 03 Jul 2024
Zamaneh Mikhak Chief Medical Officer $61,005 03 Jul 2024
Robert S. Mills Director $24,989 03 Jul 2024
Kirk Allen Coleman Chief Financial Officer $22,109 03 Jul 2024
Stephen Rocamboli Director $17,165 03 Jul 2024
Glenn R. Mattes President and CEO, Director $16,839 16 May 2022
Brandi Roberts Director $11,159 03 Jul 2024
Catherine C. Lee Director $2,013 03 Jul 2024
Thomas B. King Director $1,838 03 Jul 2024
Michael A. Patane Director $1,393 18 Apr 2024
Christopher Cano Chief Operating Officer 22 Sep 2021
Randy H. Thurman Director 29 Sep 2022
Aaron G.l. Fletcher Director 29 Dec 2022

Recent Insider Transactions by Companies or Individuals for TFF Pharmaceuticals, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
Harlan F. Weisman Common Stock Award 3.37% 27,480 842,095 03 Jul 2024 Direct
Harlan F. Weisman Stock Options (Right to Buy) Award 27,480 27,480 03 Jul 2024 Direct
Catherine C. Lee Common Stock Award 1,583 1,583 03 Jul 2024 Direct
Catherine C. Lee Stock Options (Right to Buy) Award 1,583 1,583 03 Jul 2024 Direct
Robert S. Mills Common Stock Award 5.65% 3,165 59,145 03 Jul 2024 Direct
Robert S. Mills Stock Options (Right to Buy) Award 3,165 3,165 03 Jul 2024 Direct
Brandi Roberts Common Stock Award 15.8% 3,165 23,165 03 Jul 2024 Direct
Brandi Roberts Stock Options (Right to Buy) Award 3,165 3,165 03 Jul 2024 Direct
Kirk Allen Coleman Common Stock Award 28.6% 10,184 45,859 03 Jul 2024 Direct
Kirk Allen Coleman Stock Options (Right to Buy) Award 10,184 10,184 03 Jul 2024 Direct
Zamaneh Mikhak Common Stock Award 7.54% 10,184 145,184 03 Jul 2024 Direct
Zamaneh Mikhak Stock Options (Right to Buy) Award 10,184 10,184 03 Jul 2024 Direct
Stephen Rocamboli Common Stock Award 8.79% 3,165 39,165 03 Jul 2024 Direct
Stephen Rocamboli Stock Options (Right to Buy) Award 3,165 3,165 03 Jul 2024 Direct
Thomas B. King Common Stock Award 1,583 1,583 03 Jul 2024 Direct
Thomas B. King Stock Options (Right to Buy) Award 1,583 1,583 03 Jul 2024 Direct
Thomas B. King Restricted stock units Award 3,110 3,110 18 Apr 2024 Direct
Michael A. Patane Restricted stock units Award 3,556 3,556 18 Apr 2024 Direct
Catherine C. Lee Restricted stock units Award 3,556 3,556 18 Apr 2024 Direct
Robert S. Mills Restricted stock units Award 4,667 4,667 18 Apr 2024 Direct
Brandi Roberts Restricted stock units Award 5,333 5,333 18 Apr 2024 Direct
Kirk Allen Coleman Restricted stock units Award 15,900 10,600 18 Apr 2024 Direct
Zamaneh Mikhak Restricted stock units Award 15,900 10,600 18 Apr 2024 Direct
Stephen Rocamboli Restricted stock units Award 4,667 4,667 18 Apr 2024 Direct
Harlan F. Weisman Restricted stock units Award 44,967 44,967 18 Apr 2024 Direct
Thomas B. King Stock Options (Right to Buy) Award 132,442 132,442 13 Dec 2023 Direct
Brandi Roberts Stock Options (Right to Buy) Award 52,858 52,858 01 Dec 2023 Direct
Robert S. Mills Stock Options (Right to Buy) Award 52,858 52,858 01 Dec 2023 Direct
Stephen Rocamboli Stock Options (Right to Buy) Award 52,858 52,858 01 Dec 2023 Direct
Michael A. Patane Stock Options (Right to Buy) Award 132,442 132,442 01 Dec 2023 Direct
Catherine Chai-Zon Lee Stock Options (Right to Buy) Award 132,442 132,442 01 Dec 2023 Direct
Carlson Capital L P Common Stock Sale -0.02% $392 $0.3916 -1,000 5,064,000 16 Aug 2023 See footnotes
Zamaneh Mikhak Common Stock Purchase 800% $30,000 $0.2500 120,000 135,000 15 Aug 2023 Direct
Kirk Allen Coleman Common Stock Purchase 127.6% $5,000 $0.2500 20,000 35,675 15 Aug 2023 Direct
Carlson Capital L P Common Stock, par value $0.001 per share (the "Common Stock" Sale -4.07% $94,041 $0.4374 -215,000 5,065,000 15 Aug 2023 See footnotes
Harlan F. Weisman Common Stock Purchase 279.6% $150,000 $0.2500 600,000 814,615 15 Aug 2023 Direct
Brandi Roberts Common Stock Purchase $5,000 $0.2500 20,000 20,000 15 Aug 2023 Direct
Robert S. Mills Common Stock Purchase 250.3% $10,000 $0.2500 40,000 55,980 15 Aug 2023 Direct
Stephen Rocamboli Common Stock Purchase 125% $5,000 $0.2500 20,000 36,000 15 Aug 2023 Direct
Kirk Allen Coleman Stock Options (Right to Buy) Award 100,000 100,000 22 Mar 2023 Direct
Kirk Allen Coleman Common Stock Purchase 326.5% $9,457 $0.7881 12,000 15,675 10 Mar 2023 Direct
Zamaneh Mikhak Common Stock Purchase $12,300 $0.8200 15,000 15,000 10 Mar 2023 Direct
Harlan F. Weisman Common Stock Purchase 232.1% $131,835 $0.8789 150,000 214,615 10 Mar 2023 Direct
Stephen Rocamboli Common Stock Purchase 433.3% $10,432 $0.8025 13,000 16,000 10 Mar 2023 Direct
Aaron G.l. Fletcher Stock Options (Right to Buy) Award 33,475 33,475 29 Dec 2022 To BP Directors for the benefit of Reporting Person
Brandi Roberts Stock Options (Right to Buy) Award 20,968 20,968 29 Dec 2022 Direct
Robert S. Mills Stock Options (Right to Buy) Award 33,475 33,475 29 Dec 2022 Direct
Stephen Rocamboli Stock Options (Right to Buy) Award 33,475 33,475 29 Dec 2022 Direct
Harlan F. Weisman Common Stock Purchase 342.1% $53,000 $1.06 50,000 64,615 15 Dec 2022 Direct
Harlan F. Weisman Stock Options (Right to Buy) Award 1,792,450 1,792,450 03 Dec 2022 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.